 0 Table of Contents |
  1 Home |
  2 Overview |
  3 UseCase |
  4 Guidance |
  5 Patient-Generated Health Data (PGHD) |
  6 Oncology |
  7 Continuous Glucose Monitoring (CGM) |
  8 Release Notes |
  9 Artifacts Summary |
   9.1 Fujitsu DocumentReference ($docref) |
   9.2 FujitsuAppointmentEverything |
   9.3 GAD-7 assesment |
   9.4 PHQ-9 assesment |
   9.5 Fujitsu Adverse Event Clinical Research |
   9.6 Fujitsu AllergyIntolerance Profile |
   9.7 Fujitsu Appointment Profile |
   9.8 Fujitsu Cancer-Related Medication Administration Injection Profile |
   9.9 Fujitsu Cancer-Related Medication Administration Profile |
   9.10 Fujitsu Cancer-Related Medication Request Injection Profile |
   9.11 Fujitsu Cancer-Related Medication Request Profile |
   9.12 Fujitsu Cancer-Related Surgical Procedure Profile |
   9.13 Fujitsu CarePlan Profile |
   9.14 Fujitsu CGM Data Submission Bundle |
   9.15 Fujitsu Condition Profile |
   9.16 Fujitsu Consent Profile |
   9.17 Fujitsu Device Profile |
   9.18 Fujitsu DiagnosticReport LabResult Profile |
   9.19 Fujitsu DocumentReference Profile |
   9.20 Fujitsu Encounter Profile |
   9.21 Fujitsu Genomics Report Profile |
   9.22 Fujitsu HealthcareService Appointment Profile |
   9.23 Fujitsu Immunization Profile |
   9.24 Fujitsu Location Profile |
   9.25 Fujitsu Medication Profile |
   9.26 Fujitsu MedicationAdministration Injection Profile |
   9.27 Fujitsu MedicationAdministration Insulin Profile |
   9.28 Fujitsu MedicationAdministration Profile |
   9.29 Fujitsu MedicationDispense Injection Profile |
   9.30 Fujitsu MedicationDispense Profile |
   9.31 Fujitsu MedicationRequest Injection Profile |
   9.32 Fujitsu MedicationRequest Profile |
   9.33 Fujitsu MedicationStatement Profile |
   9.34 Fujitsu Observation Activity Profile |
   9.35 Fujitsu Observation AlcholConsumption Profile |
   9.36 Fujitsu Observation AlcholUse Profile |
   9.37 Fujitsu Observation Audiogram Profile |
   9.38 Fujitsu Observation BloodGlucose Profile |
   9.39 Fujitsu Observation BloodPressure Profile |
   9.40 Fujitsu Observation BMI Profile |
   9.41 Fujitsu Observation Body Measurement Profile |
   9.42 Fujitsu Observation BodyHeight Profile |
   9.43 Fujitsu Observation BodyTemperature Profile |
   9.44 Fujitsu Observation BodyWeight Profile |
   9.45 Fujitsu Observation Cancer Disease Status Profile |
   9.46 Fujitsu Observation Cancer Stage Profile |
   9.47 Fujitsu Observation Cardiac Function Profile |
   9.48 Fujitsu Observation CGM Coefficient of Variation (CV) Profile |
   9.49 Fujitsu Observation CGM Days of Wear Profile |
   9.50 Fujitsu Observation CGM Glucose Management Indicator (GMI) Profile |
   9.51 Fujitsu Observation CGM Mean Glucose (Mass) Profile |
   9.52 Fujitsu Observation CGM Mean Glucose (Moles) Profile |
   9.53 Fujitsu Observation CGM Profile |
   9.54 Fujitsu Observation CGM Sensor Active Percentage Profile |
   9.55 Fujitsu Observation CGM Sensor Reading (Mass) Profile |
   9.56 Fujitsu Observation CGM Sensor Reading (Molar) Profile |
   9.57 Fujitsu Observation CGM Summary PDF Report Profile |
   9.58 Fujitsu Observation CGM Summary Profile |
   9.59 Fujitsu Observation CGM Summary Times in Ranges Profile |
   9.60 Fujitsu Observation CLL Binet Stage Profile |
   9.61 Fujitsu Observation CLL Rai Stage Profile |
   9.62 Fujitsu Observation Common Profile |
   9.63 Fujitsu Observation Comorbidities Profile |
   9.64 Fujitsu Observation Diving Profile |
   9.65 Fujitsu Observation ECOG Performance Status Profile |
   9.66 Fujitsu Observation Electrocardiogram Profile |
   9.67 Fujitsu Observation Food Profile |
   9.68 Fujitsu Observation Genomic Region Studied Profile |
   9.69 Fujitsu Observation Genomic Variant Profile |
   9.70 Fujitsu Observation Gynecologic Tumor FIGO Stage Profile |
   9.71 Fujitsu Observation HeadCircum Profile |
   9.72 Fujitsu Observation Hearing Profile |
   9.73 Fujitsu Observation HearingSensitivity Profile |
   9.74 Fujitsu Observation Heartbeat Profile |
   9.75 Fujitsu Observation HeartRate Profile |
   9.76 Fujitsu Observation History of Metastatic Cancer Profile |
   9.77 Fujitsu Observation Karnofsky Performance Status Profile |
   9.78 Fujitsu Observation LabResult Profile |
   9.79 Fujitsu Observation Lymph Node Invasion Profile |
   9.80 Fujitsu Observation Lymphoma Stage Profile |
   9.81 Fujitsu Observation MedicationAdherence Profile |
   9.82 Fujitsu Observation Melanoma Breslow Depth Stage Profile |
   9.83 Fujitsu Observation Melanoma Clark Level Profile |
   9.84 Fujitsu Observation MET by Standard RMR Profile |
   9.85 Fujitsu Observation Microsatellite Instability Profile |
   9.86 Fujitsu Observation Mindfulness Profile |
   9.87 Fujitsu Observation Mobility Profile |
   9.88 Fujitsu Observation Myeloma ISS Stage Profile |
   9.89 Fujitsu Observation Myeloma RISS Stage Profile |
   9.90 Fujitsu Observation Nutrition Profile |
   9.91 Fujitsu Observation OxygenSaturation Profile |
   9.92 Fujitsu Observation Parent for T, N, and M Categories Profile |
   9.93 Fujitsu Observation Pregnancy Status Profile |
   9.94 Fujitsu Observation Prostate Gleason Grade Group Profile |
   9.95 Fujitsu Observation ReproductiveHealth Profile |
   9.96 Fujitsu Observation RespiratoryRate Profile |
   9.97 Fujitsu Observation Scored Assessment Profile |
   9.98 Fujitsu Observation SelfCare Profile |
   9.99 Fujitsu Observation Sleep Profile |
   9.100 Fujitsu Observation SleepEpisode Profile |
   9.101 Fujitsu Observation SnoreEvent Profile |
   9.102 Fujitsu Observation SnoreIndex Profile |
   9.103 Fujitsu Observation State of Mind Profile |
   9.104 Fujitsu Observation Symptom Profile |
   9.105 Fujitsu Observation TestResult Profile |
   9.106 Fujitsu Observation TNM Distant Metastases Category Profile |
   9.107 Fujitsu Observation TNM Primary Tumor Category Profile |
   9.108 Fujitsu Observation TNM Regional Nodes Category Profile |
   9.109 Fujitsu Observation TNM Stage Group Profile |
   9.110 Fujitsu Observation Tumor Marker Test Profile |
   9.111 Fujitsu Observation Tumor Mutation Burden Profile |
   9.112 Fujitsu Observation Tumor Size Profile |
   9.113 Fujitsu Observation UVExposure Profile |
   9.114 Fujitsu Observation Vital Signs Profile |
   9.115 Fujitsu Observation VoltageMeasurement Profile |
   9.116 Fujitsu Observation Workout Profile |
   9.117 Fujitsu Oncology Patient Group Profile |
   9.118 Fujitsu Oncology Specimen Profile |
   9.119 Fujitsu Organization Profile |
   9.120 Fujitsu Patient Profile |
   9.121 Fujitsu Practitioner Profile |
   9.122 Fujitsu PractitionerRole Profile |
   9.123 Fujitsu Primary Cancer Condition Profile |
   9.124 Fujitsu Procedure Profile |
   9.125 Fujitsu Questionnaire Profile |
   9.126 Fujitsu QuestionnaireResponse Profile |
   9.127 Fujitsu Radiotherapy Course Summary Profile |
   9.128 Fujitsu Radiotherapy Volume Profile |
   9.129 Fujitsu Secondary Cancer Condition Profile |
   9.130 Fujitsu SelfCare Plan Profile |
   9.131 Fujitsu Specimen Profile |
   9.132 Fujitsu Tumor Profile |
   9.133 Fujitsu Body Structure Identifier Profile |
   9.134 Fujitsu Adverse event caused subject to discontinue the study |
   9.135 Fujitsu Adverse Event Grade |
   9.136 Fujitsu Adverse Event resolution date |
   9.137 Fujitsu Body Location Qualifier Extension |
   9.138 Fujitsu Body Location Qualifier Extension |
   9.139 Fujitsu Contributing Factor |
   9.140 Fujitsu Criteria reviewed in determining serious adverse event |
   9.141 Fujitsu elated Condition Absent Extension |
   9.142 Fujitsu Expected In Research Study |
   9.143 Fujitsu HeartRate Rhythm Extension |
   9.144 Fujitsu Histology Morphology Behavior Extension |
   9.145 Fujitsu Hours After Meal Extension |
   9.146 Fujitsu Mitigating Action |
   9.147 Fujitsu Note |
   9.148 Fujitsu Participant |
   9.149 Fujitsu Procedure Intent Extension |
   9.150 Fujitsu Radiotherapy Dose Delivered To Volume Extension |
   9.151 Fujitsu Radiotherapy Modality And Technique Extension |
   9.152 Fujitsu Radiotherapy Modality Extension |
   9.153 Fujitsu Radiotherapy Number of Sessions Extension |
   9.154 Fujitsu Radiotherapy Technique Extension |
   9.155 Fujitsu Related Condition Extension |
   9.156 Fujitsu Relationship To Physical Ativity Extension |
   9.157 Fujitsu Relationship To Sleep Extension |
   9.158 Fujitsu Research Subject record of subject |
   9.159 Fujitsu Resulting Effect |
   9.160 Fujitsu Supporting information relevant to the event |
   9.161 Fujitsu Suspect Entity |
   9.162 Fujitsu Treatment Termination Reason Extension |
   9.163 Fujitsu Workflow Status |
   9.164 Benign Neoplasm of Brain and CNS Disorder ValueSet |
   9.165 Body Location And Laterality Qualifier ValueSet |
   9.166 Body Location Qualifier ValueSet |
   9.167 Body Temperature Measurement Location Codes |
   9.168 Cancer Body Location ValueSet |
   9.169 Cancer Disorder ValueSet |
   9.170 Cancer Stage ValueSet |
   9.171 Cancer Staging Method ValueSet |
   9.172 Cancer Staging Type ValueSet |
   9.173 Carcinoma In-Situ Disorder ValueSet |
   9.174 Clark Level ValueSet |
   9.175 Condition BodySite Codes |
   9.176 Condition Codes |
   9.177 Condition Status Trend ValueSet |
   9.178 ECG Classification Codes |
   9.179 ECG Lead Codes |
   9.180 ECG Lead Codes |
   9.181 ECG Symptoms Status Codes |
   9.182 FIGO Stage ValueSet |
   9.183 FIGO Staging Method ValueSet |
   9.184 FIGO Staging Method ValueSet |
   9.185 FIGO Staging Method ValueSet |
   9.186 Fujitsu Internal Identifier URI |
   9.187 Fujitsu Medication Unit MERIT9 |
   9.188 Fujitsu UCUM |
   9.189 Gleason Grade ValueSet |
   9.190 Histology Morphology Behavior ValueSet |
   9.191 History of Metastatic Malignant Neoplasm ValueSet |
   9.192 International Staging System (ISS) for Myeloma Stage ValueSet |
   9.193 Laterality Qualifier ValueSet |
   9.194 Lymphoma Stage ValueSet |
   9.195 Lymphoma Staging System ValueSet |
   9.196 Medication Method Injection Codes |
   9.197 Medication Method Prescription Codes |
   9.198 Melanoma In-Situ Disorder ValueSet |
   9.199 Morphology ValueSet |
   9.200 Observation Activity Codes |
   9.201 Observation AlcholConsumption Codes |
   9.202 Observation BloodGlucose Codes |
   9.203 Observation BodyMesurements Codes |
   9.204 Observation CGM Codes |
   9.205 Observation Diving Codes |
   9.206 Observation GAD7 Risk Codes |
   9.207 Observation Hearing Codes |
   9.208 Observation LabResults Codes |
   9.209 Observation Mind Codes |
   9.210 Observation Mindfulness Codes |
   9.211 Observation Mobility Codes |
   9.212 Observation Nutrition Codes |
   9.213 Observation PHQ9Risk Codes |
   9.214 Observation ReproductiveHealth Codes |
   9.215 Observation Scored Assessment Codes |
   9.216 Observation SelfCare Codes |
   9.217 Observation Sleep Codes |
   9.218 Observation State of Mind Association Codes |
   9.219 Observation State of Mind Codes |
   9.220 Observation State of Mind Codes |
   9.221 Observation State of Mind Kind Codes |
   9.222 Observation State of Mind Label Codes |
   9.223 Observation State of Mind Valence Codes |
   9.224 Observation Symptom Codes |
   9.225 Observation UVExposure Codes |
   9.226 Observation Vitalsigns Codes |
   9.227 Observation Workout Codes |
   9.228 Performance Status ValueSet |
   9.229 Primary Cancer Disorder ValueSet |
   9.230 Primary Malignant Neoplasm Disorder ValueSet |
   9.231 Procedure Intent Qualifier ValueSet |
   9.232 Radiotherapy Modality ValueSet |
   9.233 Radiotherapy Technique ValueSet |
   9.234 Radiotherapy Treatment Location Qualifier ValueSet |
   9.235 Radiotherapy Treatment Location ValueSet |
   9.236 Radiotherapy Volume Type ValueSet |
   9.237 Rai Stage ValueSet |
   9.238 Rai Staging System ValueSet |
   9.239 Revised International Staging System (RISS) for Myeloma Stage ValueSet |
   9.240 Secondary Cancer Disorder ValueSet |
   9.241 Sleep Analysis |
   9.242 Source for Adjusted MET Codes |
   9.243 Source for Estimated MET Codes |
   9.244 Source for Reported MET Codes |
   9.245 Specific Diagnosis of Cancer ValueSet |
   9.246 Specimen Codes |
   9.247 Symptom Appetite Changes |
   9.248 Symptom Presence |
   9.249 Symptom Severity |
   9.250 Temporal relationship to physical activity Codes |
   9.251 Temporal relationship to sleep Codes |
   9.252 TNM Distant Metastases Category ValueSet |
   9.253 TNM Distant Metastases Staging Type ValueSet |
   9.254 TNM Primary Tumor Category ValueSet |
   9.255 TNM Primary Tumor Staging Type ValueSet |
   9.256 TNM Regional Nodes Category Staging Type ValueSet |
   9.257 TNM Regional Nodes Category ValueSet |
   9.258 TNM Stage Group Staging Type ValueSet |
   9.259 TNM Stage Group ValueSet |
   9.260 TNM Staging Method ValueSet |
   9.261 Treatment Termination Reason ValueSet |
   9.262 Tumor Marker Test ValueSet |
   9.263 Tumor Size Method ValueSet |
   9.264 UCUM Body Length Units |
   9.265 UCUM Body Temprature Units |
   9.266 UCUM Body Weight Units |
   9.267 UCUM Vital Signs Units |
   9.268 Vital Signs Loinc Codes |
   9.269 Appetite Changes Codes |
   9.270 Body Posture Codes |
   9.271 Body Temperature Measurement Location Codes |
   9.272 Cancer Stage |
   9.273 Cancer Staging Method |
   9.274 Cancer Staging Type |
   9.275 Clark Level ValueSet |
   9.276 Condition BodySite Codes |
   9.277 Condition BodySite Qualifier Codes |
   9.278 Condition Status Trend Codes |
   9.279 ECG Classification Codes |
   9.280 ECG Classification Codes |
   9.281 ECG Lead Codes |
   9.282 ECG Symptoms Status Codes |
   9.283 FIGO Stage |
   9.284 FIGO Staging Method |
   9.285 FIGO Staging Method |
   9.286 FIGO Staging Method |
   9.287 Fujitsu Internal Identifier URI |
   9.288 GAD-7 Assesment Risk Codes |
   9.289 Gleason Grade ValueSet |
   9.290 Hearing Sensitivity Codes |
   9.291 History of Metastatic Malignant Neoplasm ValueSet |
   9.292 ICD-O-3 |
   9.293 ICD10 Codes |
   9.294 International Staging System (ISS) for Myeloma Stage ValueSet |
   9.295 JLAC10 Specimen Codes |
   9.296 Loinc Codes |
   9.297 Lymphoma Stage ValueSet |
   9.298 Lymphoma Staging System ValueSet |
   9.299 Observation PHR Codes |
   9.300 PHQ-9 Assesment Risk Codes |
   9.301 Procedure Intent Qualifier ValueSet |
   9.302 Radiotherapy Modality Codes |
   9.303 Radiotherapy Modality Codes |
   9.304 Radiotherapy Treatment Location Qualifier ValueSet |
   9.305 Radiotherapy Volume Type Codes |
   9.306 Rai Stage ValueSet |
   9.307 Rai Staging System |
   9.308 Revised International Staging System (RISS) for Myeloma Stage ValueSet |
   9.309 Scored Assessment Codes |
   9.310 Sleep Analysis Codes |
   9.311 Sleep Episode Codes |
   9.312 Snore Event Item Codes |
   9.313 State of Mind Association Codes |
   9.314 State of Mind Codes |
   9.315 State of Mind Kind Codes |
   9.316 State of Mind Label Codes |
   9.317 State of Mind Valence Codes |
   9.318 Symptom Presence Codes |
   9.319 Symptom Severity Codes |
   9.320 Temporal relationship to physical activity |
   9.321 Temporal relationship to sleep |
   9.322 TNM Distant Metastases Category |
   9.323 TNM Primary Tumor Category |
   9.324 TNM Regional Nodes Category |
   9.325 TNM Stage Group |
   9.326 TNM Staging Method |
   9.327 Treatment Termination Reason ValueSet |
   9.328 Tumor Size Method ValueSet |
   9.329 UCUM Codes |
   9.330 (K0771)FLU/CY |
   9.331 adverse-event-compass-ex1 |
   9.332 adverse-event-compass-ex1a |
   9.333 adverse-event-compass-ex1b |
   9.334 adverse-event-compass-ex2 |
   9.335 adverse-event-device-death |
   9.336 AdverseEventFromProcedureNotStudyDrug |
   9.337 AEHeadache |
   9.338 AEHepaticFailure |
   9.339 AEHepaticFailurecomplication |
   9.340 AEModeratehives |
   9.341 AllergyIntoleranceExample |
   9.342 AppointmentExample |
   9.343 BloodPressureExample |
   9.344 BMIExample |
   9.345 BMIExample1 |
   9.346 BodyHeightExample |
   9.347 BodyHeightExample1 |
   9.348 BodyStructureTumorExample |
   9.349 BodyTemperatureExample |
   9.350 BodyTemperatureExample1 |
   9.351 BodyTemperatureExample2 |
   9.352 BodyWeightExample |
   9.353 BodyWeightExample1 |
   9.354 Breast Cancer Trial |
   9.355 CGM Sensor Reading (Mass) Example |
   9.356 CGM Sensor Reading (Molar) Example |
   9.357 CGM Summary Example |
   9.358 CGM Summary Times in Ranges Example |
   9.359 clinical-trial-acme-procedure |
   9.360 clinical-trial-acme-subject |
   9.361 clinical-trial-example-compass |
   9.362 clinical-trial-example-subject |
   9.363 clinical-trial-example-subject1 |
   9.364 ClinicalTrialSignificantAdverseEvent |
   9.365 ClinicalTrialSubject5 |
   9.366 Coefficient of Variation Example |
   9.367 ComorbiditiesExample |
   9.368 ConditionAbsentExample |
   9.369 ConditionExample |
   9.370 ConditionPrimaryCancerExample |
   9.371 ConditionSecondaryCancerExample |
   9.372 ConsentExample |
   9.373 Days of Wear Example |
   9.374 Device - Infuser that exploded |
   9.375 DeviceExample |
   9.376 DiagnosticReportGenomicsReportExample |
   9.377 DocumentReferenceExample |
   9.378 EKGExample |
   9.379 EncounterDummyCaseExample |
   9.380 EncounterHospitalizationExample |
   9.381 EncounterOutpatientCaseExample |
   9.382 Example patient SLP |
   9.383 FujitsuHealthcareServiceExample |
   9.384 GIBleed |
   9.385 GMI Example |
   9.386 HeadCircumExample |
   9.387 HeartRateExample |
   9.388 HeartRateExample1 |
   9.389 HeartRateExample2 |
   9.390 HeartRateExample3 |
   9.391 HeartRateExample4 |
   9.392 HistoryOfMetastaticCancerExample |
   9.393 ImmunizationExample |
   9.394 ImmunizationOccurrenceAbsentExample |
   9.395 Janet allergy med |
   9.396 Janet Blood Pressure Observation |
   9.397 Janet Patient |
   9.398 Janet pill for water retention med not known |
   9.399 Janet Tylenol PM med |
   9.400 Janet weight Observation |
   9.401 LabResultAbsentExample |
   9.402 LabResultExample |
   9.403 LabResultExample2 |
   9.404 LocationExample |
   9.405 Mean Glucose (Mass) Example |
   9.406 Mean Glucose (Molar) Example |
   9.407 Medication Administration for bresentrik |
   9.408 Medication Administration of Med0301 |
   9.409 Medication is bresentrik |
   9.410 Medication Request for bresentrik |
   9.411 Medication Request for discontinued clinical trial medication 0301 |
   9.412 Medication Request for discontinued clinical trial medication ABC |
   9.413 medication-administration-contrast-dye |
   9.414 medication-administration-forhives |
   9.415 medication-administration-kadcyla |
   9.416 medication-administration-kadcyla-reduced |
   9.417 medication-administration-kadcyla1 |
   9.418 medication-administration-tucatinib |
   9.419 medication-administration-tucatinib-reduced |
   9.420 medication-administration-tylenol |
   9.421 medication-request-example-kadcyla |
   9.422 medication-request-example-kadcyla1 |
   9.423 medication-request-example-tucatinib |
   9.424 medication-request-example-zofran |
   9.425 MedicationAdministrationCancerRelatedExample |
   9.426 MedicationAdministrationExample |
   9.427 MedicationAdministrationInjectionExample |
   9.428 MedicationAdministrationInsulinExample-1 |
   9.429 MedicationAdministrationInsulinExample-2 |
   9.430 MedicationDispenseExample1 |
   9.431 MedicationDispenseInjectionExample |
   9.432 MedicationRequestCancerRelatedInjectionExample |
   9.433 MedicationRequestExample |
   9.434 MedicationRequestExample2 |
   9.435 MedicationRequestInjectionExample |
   9.436 MedicationStatementExample |
   9.437 MedicationUnitAbsentExample |
   9.438 NonSeriousAdverseEventResearchStudyMed |
   9.439 ObservationActivityDistanceExample1 |
   9.440 ObservationActivityElevationGainedExample1 |
   9.441 ObservationActivityExample |
   9.442 ObservationActivityMetByStandardRmrExample1 |
   9.443 ObservationActivityMetByStandardRmrExample2 |
   9.444 ObservationActivityMetExample |
   9.445 ObservationActivityModerateActivityExample1 |
   9.446 ObservationActivityModerateToVigorousActivityExample |
   9.447 ObservationActivityPaceExample |
   9.448 ObservationActivityRunningSpeedExample1 |
   9.449 ObservationActivityStepCountExample |
   9.450 ObservationActivityStepCountExample1 |
   9.451 ObservationActivityStepsCadenceExample1 |
   9.452 ObservationActivityTotalEnergyBurnedExample |
   9.453 ObservationActivityTotalEnergyBurnedExample1 |
   9.454 ObservationActivityVigorousActivityExample1 |
   9.455 ObservationAlcholConsumptionExample |
   9.456 ObservationAlcholUseExample |
   9.457 ObservationAudiogramExample |
   9.458 ObservationBloodGlucoseExample1 |
   9.459 ObservationBloodGlucoseExample2 |
   9.460 ObservationBloodGlucoseExample3 |
   9.461 ObservationBodyFatPercentageExample |
   9.462 ObservationCardiacFunctionRrIntervalExample |
   9.463 ObservationCLLBinetStageExample |
   9.464 ObservationCLLRaiStageExample |
   9.465 ObservationDivingExample |
   9.466 ObservationElectrocardiogramExample |
   9.467 ObservationFoodExample |
   9.468 ObservationGenomicRegionStudiedExample |
   9.469 ObservationGenomicVariantExample |
   9.470 ObservationGynecologicTumorFIGOStageExample |
   9.471 ObservationHearingExample |
   9.472 ObservationHearingSensitivity1000Example |
   9.473 ObservationHearingSensitivity2000Example |
   9.474 ObservationHearingSensitivity250Example |
   9.475 ObservationHearingSensitivity4000Example |
   9.476 ObservationHearingSensitivity500Example |
   9.477 ObservationHearingSensitivity8000Example |
   9.478 ObservationLowHeartRateEventExample |
   9.479 ObservationLymphomaStageExample |
   9.480 ObservationMedicationAdherenceExample |
   9.481 ObservationMelanomaBreslowDepthStageExample |
   9.482 ObservationMelanomaClarkLevelExample |
   9.483 ObservationMindfulnessExample |
   9.484 ObservationMobilityExample |
   9.485 ObservationMyelomaISSStageExample |
   9.486 ObservationMyelomaRISSStageExample |
   9.487 ObservationNutritionDietaryCarbohydratesExample1 |
   9.488 ObservationNutritionDietaryCarbohydratesExample2 |
   9.489 ObservationNutritionDietaryEnergyConsumedExample1 |
   9.490 ObservationNutritionDietaryEnergyConsumedExample2 |
   9.491 ObservationNutritionExample |
   9.492 ObservationPregnancyExample |
   9.493 ObservationProstateGleasonGradeGroupExample |
   9.494 observationReproductiveHealthIntermenstrualBleeding |
   9.495 ObservationRespiratoryBreathCarbonMonoxideExample |
   9.496 ObservationRespiratoryInspiratoryTimeExample |
   9.497 ObservationRespiratoryMinuteVolumeExample |
   9.498 ObservationRespiratoryVentilationCycleTimeExample |
   9.499 ObservationSelfCareExample |
   9.500 ObservationSleepAhiExample |
   9.501 ObservationSleepArousalIndexExample |
   9.502 ObservationSleepEpisodeCoreSleepExample1 |
   9.503 ObservationSleepEpisodeCoreSleepExample2 |
   9.504 ObservationSleepEpisodeDeepSleepExample1 |
   9.505 ObservationSleepEpisodeDeepSleepExample2 |
   9.506 ObservationSleepEpisodeExample1 |
   9.507 ObservationSleepEpisodeExample2 |
   9.508 ObservationSleepEpisodeLatencyToSleepOnsetExample1 |
   9.509 ObservationSleepEpisodeLatencyToSleepOnsetExample2 |
   9.510 ObservationSleepExample |
   9.511 ObservationSnoreEventExample1 |
   9.512 ObservationSnoreEventExample2 |
   9.513 ObservationSnoreEventExample3 |
   9.514 ObservationSnoreIndexExample1 |
   9.515 ObservationSnoreIndexExample2 |
   9.516 ObservationSymptomExample |
   9.517 ObservationTNMDistantMetastasesCategoryExample |
   9.518 ObservationTNMPrimaryTumorCategoryExample |
   9.519 ObservationTNMRegionalNodesCategoryExample |
   9.520 ObservationTNMStageGroupExample |
   9.521 ObservationTumorMarkerTestExample |
   9.522 ObservationTumorSizeExample |
   9.523 ObservationUVExposureExample |
   9.524 ObservationVoltageMeasurementExample |
   9.525 ObservationWorkoutJumpRopeExample |
   9.526 ObservationWorkoutRunningExample |
   9.527 OperationAbsentExample |
   9.528 OperationExample |
   9.529 OrganizationExample |
   9.530 OxygenSaturationExample |
   9.531 Patient MOUMIC |
   9.532 Patient reported AE during research study |
   9.533 patient-example-kaitlyn-b |
   9.534 patient-example-kaitlyn-b1 |
   9.535 PatientExample |
   9.536 PerformanceStatusKarnofskyExample |
   9.537 phr-heartbeat |
   9.538 practitioner-oncology-nurse-jane |
   9.539 practitioner-owen-oncologist |
   9.540 PractitionerExample |
   9.541 PractitionerRoleExample |
   9.542 Problem |
   9.543 procedure-upper-endoscopy |
   9.544 Provenance for Janet Blood Pressure Observation |
   9.545 Provenance for Janet weight Observation |
   9.546 QuestionnaireResponseExample |
   9.547 QuestionnaireResponseScoredAssessmentGAD7Example |
   9.548 QuestionnaireResponseScoredAssessmentPHQ9Example |
   9.549 RadiationTherapyAbsentExample |
   9.550 RadiationTherapyExample |
   9.551 RadiotherapyCourseSummaryExample |
   9.552 RadiotherapyVolumeExample |
   9.553 research-study-acme |
   9.554 research-study-DISNEY |
   9.555 research-study-XYZ |
   9.556 RespiratoryRateExample |
   9.557 RespiratoryRateExample1 |
   9.558 RespiratoryRateExample2 |
   9.559 RespiratoryRateExample3 |
   9.560 ScoredAssessmentGAD7Example |
   9.561 ScoredAssessmentPHQ9Example |
   9.562 Sensor Active Percentage Example |
   9.563 Serious Adverse Event |
   9.564 SeriousAdverseEventResearchStudy |
   9.565 SpecimenAbsentExample |
   9.566 SpecimenExample |
   9.567 SpecimenOncologyExample |
   9.568 StateOfMind2Example |
   9.569 StateOfMindExample |
   9.570 study-medication-administration-ABC |
   9.571 study-medication-administration-MMD |
   9.572 study-medication-administration-WBY |
   9.573 SurgicalProcedureCancerRelatedExample |
   9.574 仕事と機能能力の自己評価 |
   9.575 腰痛や怪我 |
   9.576 腰痛や怪我 |